Banque Cantonale Vaudoise’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Banque Cantonale Vaudoise’s Portfolio HELP Stock Details HELP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-178	Closed	-$3K	–	1188
2023 Q2	$3K	Hold	178	–	–	﹤0.01%	1150
2023 Q1	$3K	Hold	178	–	–	﹤0.01%	1154
2022 Q4	$2K	Hold	178	–	–	﹤0.01%	1173
2022 Q3	$3K	Hold	178	–	–	﹤0.01%	1204
2022 Q2	$4K	Hold	178	–	–	﹤0.01%	1230
2022 Q1	$6K	Hold	178	–	–	﹤0.01%	1239
2021 Q4	$8K	Buy	+178	New	+$11.3K	﹤0.01%	1251

Other funds holding HELP

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

IWP

IAG Wealth Partners Waukesha, Wisconsin $1.01B AUM 17.58% 1-Year Est. Return

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PIA

Powell Investment Advisors Miami, Florida $317M AUM 26.57% 1-Year Est. Return

Banque Cantonale Vaudoise's HELP Position: Q3 2023 in Review

Banque Cantonale Vaudoise sold out of Helus Pharma Inc. Common Stock (HELP) in Q3 2023, closing a stake of 178 shares — an estimated $3K sold.

Banque Cantonale Vaudoise first reported a position in HELP in Q4 2021 and held it in 7 quarters. The position peaked at $8K in Q4 2021. 70 funds tracked by Wall St. Rank hold HELP as of Q3 2023.

Banque Cantonale Vaudoise reported no remaining Helus Pharma Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Banque Cantonale Vaudoise sold 178 Helus Pharma Inc. Common Stock shares in Q3 2023, an estimated $3K.
Banque Cantonale Vaudoise first reported a position in Helus Pharma Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Banque Cantonale Vaudoise's Helus Pharma Inc. Common Stock position peaked at $8K in Q4 2021.
70 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q3 2023.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2023, filed 8 Nov 2023.